VV

Vangelis Vergetis

Founder of Epikast

New York, New York

Overview 

Vangelis Vergetis is the CEO of Epikast, a company at the forefront of healthcare, data science, and technology innovation. With a Ph.D. from the University of Pennsylvania and experience as an Associate Partner at McKinsey & Company, he has successfully led Epikast through a Series A funding round and co-founded Intelligencia AI, showcasing expertise in biotechnology, pharmaceuticals, and growth investing.

Work Experience 

E

Epikast

  • CEO & Co-founder

    2022 - Current

    Epikast partners with biopharmaceutical companies as they engage their most important stakeholders: patients, physicians, and other healthcare providers.

Healthcare services and technology

Raised $10,000,000.00 from EcoR1 Capital.

epikast.com
IA

Intelligencia AI

  • Board Advisor

    2022 - 2024

  • CEO & Co-founder

    2018 - 2022

    Intelligencia's software platform utilizes Artificial Intelligence to assess the risk of clinical trials and increase R&D productivity. Partnered with top-10 pharma companies and mid-size biotechs, scaled the company to 100+ people across the US and Europe, and raised two rounds of VC financing.

Intelligencia is a SaaS company that applies machine learning to assess and mitigate the risk in clinical development strategy/design.

Raised $15,500,000.00 from Synetro Group, ZS Associates, MTIP AG and Big Pi Ventures.

intelligencia.ai
H

Hakluyt

  • Partner

    2014 - 2018

M&

McKinsey & Company

  • Associate Partner, Healthcare Practice

    2006 - 2014

McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity

mckinsey.com

Education 

Investments 

Epikast, Inc.

Series A

Total funding amount not yet available

Intelligencia, Inc.

Angel

Total funding amount not yet available

Articles About Vangelis

Relevant Websites